Depression is partially genetic meaning that you are more likely to suffer from it if someone from your family does, too.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Leanne M. Williams ...

Explore therapeutic choices for patients with treatment-resistant depression, including ketamine, psilocybin, and various ...

Patients with major depressive disorder, including those who have not responded to first-line antidepressants, may benefit from short-term nitrous oxide treatment, a major meta-analysis led by the ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults. This approval marks ...

Just one dose of psilocybin, given with close supervision and psychological support, improved depression symptoms and functioning in people with major depressive disorder for up to six weeks, ...

Enhancing Signal Detection and Mitigating Placebo Response in Major Depressive Disorder Clinical Trials, Upcoming Webinar Hosted by Xtalks ...